Zofran Lawsuit Plaintiff Alleges Infant Developed Right Heart Syndrome After Drug Exposure

ZofranLegal.com reports on a Zofran birth defect lawsuit which was filed against pharmaceutical giant GlaxoSmithKline, who manufactures the anti-nausea drug in question. The complaint was filed by a mother from Illinois who claims that fetal exposure to the drug caused her son to develop a severe congenital heart defect while in utero. She states that defendant GSK’s, “conduct has caused devastating, irreversible, and life-long consequences and suffering to newborns and their families.” In this statement, she is referring to the many other parents from across the United States who have filed lawsuits relating to Zofran and containing strikingly similar birth defect allegations.

Court document details state that the plaintiff was prescribed Zofran while pregnant by her doctor, as is common. She used the anti-nausea drug to combat morning sickness during her first trimester. This is a typical time for expectant mothers to suffer from nausea or vomiting episodes. It is also a time, however, when the fetus’ cells begin to divide rapidly, and the baby completes much of its initial limb, heart and mouth tissue development. The woman claims that after her use of Zofran, the pregnancy progressed as normal until the day she gave birth to her son in 2012. Upon birth, the boy was suddenly diagnosed with hypoplastic right heart syndrome.

Hypoplastic right heart syndrome is the medical term for a congenital heart defect that develops when the right side of the heart becomes malformed and is unable to properly cycle and pump the body’s blood. This condition can substantially affect proper blood flow to the lungs, and those suffering from it can appear to have a bluish tinge. The plaintiff states that her son required a heart transplant surgery, which is considered quite risky on a fragile infant. Although he successfully came out of this surgery, she claims that he requires continued medical care to-date. She is requesting compensation from the defendant to help pay past, current, and future medical bills.

As lawsuits filed against GlaxoSmithKline discussing Zofran continue to mount today and are reported to number over 220, the attorneys of Monheit Law are working to help other mothers who took Zofran while expecting and who later gave birth to children with a range of defects. These women and their children deserve to be provided with the opportunity to investigate their legal rights in full. Those affected may be entitled to substantial compensation. To better assist those wishing to learn more, the attorneys of Monheit Law are offering complimentary legal consultations for qualified parties at this time.

To request more information on Zofran, or to ask questions at anytime, please contact attorney Michael Monheit of Monheit Law by calling 877-620-8411.